Rongfeng Liu

PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma

Jianfeng Wang, Chen Wang, Pan Xu et al. · Theranostics · 2021 · 61 citations · Full text

Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening

Fanwang Meng, Su-Fang Cheng, Hong Ding et al. · Journal of Medicinal Chemistry · 2015 · 60 citations · Full text

Machine-Learning-Assisted Approach for Discovering Novel Inhibitors Targeting Bromodomain-Containing Protein 4

Jing Xing, Wenchao Lu, Rongfeng Liu et al. · Journal of Chemical Information and Modeling · 2017 · 46 citations

Drug Target, Hit Identification, Molecular Biology +19

Designing an Artificial Pathway for the Biosynthesis of a Novel Phenazine <i>N</i>-Oxide in <i>Pseudomonas chlororaphis</i> HT66

Shuqi Guo, Rongfeng Liu, Wei Wang et al. · ACS Synthetic Biology · 2020 · 35 citations

Two New Antifungal Cyclic Lipopeptides from Bacillus marinus B-9987

Daojing Zhang, Rongfeng Liu, Yuanguang Li et al. · Chemical and Pharmaceutical Bulletin · 2010 · 32 citations · Full text